Hall Laurie J Trustee Ultragenyx Pharmaceutical Inc. Transaction History

Hall Laurie J Trustee

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 11, 2023	SELL	$33.72 - $46.33 $674 - $926	-20 Reduced 33.33%	40 $2,000
Q3 2022 Oct 11, 2022	SELL	$39.96 - $66.14 $1,198 - $1,984	-30 Reduced 33.33%	60 $2,000
Q3 2021 Oct 04, 2021	SELL	$77.92 - $102.4 $3,896 - $5,120	-50 Reduced 35.71%	90 $8,000
Q3 2020 Oct 09, 2020	BUY	$72.98 - $90.0 $2,919 - $3,600	40 Added 40.0%	140 $12,000
Q4 2019 Feb 12, 2020	BUY	$36.08 - $45.83 $3,608 - $4,583	100 New	100 $4,000

329

85.9M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.18B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Hall Laurie J Trustee, based on Form 13F filings with the SEC.

Stay updated on Hall Laurie J Trustee with notifications on news.